Description
The medicine regulators from Australia, Canada, Singapore, Switzerland and the United Kingdom (Access Consortium) have discussed the regulatory evidence requirements for COVID-19 vaccine approvals and considerations for post-market pharmacovigilance. This collective statement on COVID-19 vaccines builds on the Consortium's May 2020 pledge to work together to counter the COVID-19 global pandemic.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Access Consortium statement on COVID-19 vaccines evidence | HTML | Open resource | |
| Access Consortium statement on COVID-19 vaccines evidence | HTML | Open resource |